Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Reimbursement
Pharma
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
While AZ/Daiichi's Enhertu and Roche's Polivy earned national reimbursement in China, Gilead's Trodelvy and Pfizer's Besponsa didn't.
Angus Liu
Dec 4, 2024 12:52pm
BioMarin downsizes gene therapy efforts to focus on 3 markets
Aug 6, 2024 10:34am
Bluebird pushes Lyfgenia's US coverage to nearly 200M people
Jan 4, 2024 11:15am
Bluebird signs first coverage deal for SCD gene therapy Lyfgenia
Dec 14, 2023 11:04am
Is the cost of Vertex's Trikafta hampering CF treatment?
Feb 14, 2022 11:46am
Medicare received majority of comments iffy on Biogen's Aduhelm
Feb 1, 2022 11:34am
